Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients

被引：9
作者：
Oh, Yun Kyu [1 ,2 ]
Park, Hayne Cho [3 ]
Ryu, Hyunjin [1 ,4 ]
Kim, Yong-Chul [1 ,4 ]
Oh, Kook-Hwan [1 ,4 ]
机构：
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt, Boramae Med Ctr, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
[3] Hallym Univ, Dept Internal Med, Kangnam Sacred Heart Hosp, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
KOREAN JOURNAL OF INTERNAL MEDICINE | 2021年 / 36卷 / 04期
关键词：
Autosomal dominant polycystic kidney disease; PKD1; PKD2; Disease progression; Tolvaptan; VOLUME; PROGRESSION; MECHANISMS; TOLVAPTAN; GENOTYPE; OUTCOMES; ADPKD; RISK; MUTATIONS; MORTALITY;
D O I：
10.3904/kjim.2021.176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease 1 (PKD1) and PKD2 have been identified as genes related to ADPKD and their significance in the molecular pathology of the disease has been studied. A disease-modifying drug has been approved; therefore, it has become important to identify patients at a high risk of kidney disease progression. Genetic tests, image analysis methods, and clinical factors for kidney disease progression prediction have been established. This review describes genetic and clinical characteristics, and discusses ongoing studies in Korean ADPKD patients.
引用
收藏
页码：767 / 779
页数：13
相关论文
共 76 条
  • [1] Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes
    Bogdanova, N
    Markoff, A
    Gerke, V
    McCluskey, M
    Horst, J
    Dworniczak, B
    [J]. GENOMICS, 2001, 74 (03) : 333 - 341
  • [2] A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases
    Bullich, Gemma
    Domingo-Gallego, Andrea
    Vargas, Ivan
    Ruiz, Patricia
    Lorente-Grandoso, Laura
    Furlano, Monica
    Fraga, Gloria
    Madrid, Alvaro
    Ariceta, Gema
    Borregan, Mar
    Alberto Pinero-Fernandez, Juan
    Rodriguez-Pena, Lidia
    Juliana Ballesta-Martinez, Maria
    Llano-Rivas, Isabel
    Aguirre Menica, Mireia
    Ballarin, Jose
    Torrents, David
    Torra, Roser
    Ars, Elisabet
    [J]. KIDNEY INTERNATIONAL, 2018, 94 (02) : 363 - 371
  • [3] Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Carrera, Paola
    Calzavara, Silvia
    Magistroni, Riccardo
    den Dunnen, Johan T.
    Rigo, Francesca
    Stenirri, Stefania
    Testa, Francesca
    Messa, Piergiorgio
    Cerutti, Roberta
    Scolari, Francesco
    Izzi, Claudia
    Edefonti, Alberto
    Negrisolo, Susanna
    Benetti, Elisa
    Alibrandi, Maria Teresa Sciarrone
    Manunta, Paolo
    Boletta, Alessandra
    Ferrari, Maurizio
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [4] Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
    Cha, Ran-hui
    Kim, Su Hyun
    Bae, Eun Hui
    Yu, Mina
    Choi, Beom Soon
    Choi, Hoon Young
    Kang, Sun Woo
    Shin, Jungho
    Han, Sang Youb
    Yang, Chul Woo
    Kang, Duk-Hee
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (03) : 373 - 381
  • [5] Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies
    Chapman, Arlene B.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (04): : 1197 - 1204
  • [6] Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
    Chapman, Arlene B.
    Devuyst, Olivier
    Eckardt, Kai-Uwe
    Gansevoort, Ron T.
    Harris, Tess
    Horie, Shigeo
    Kasiske, Bertram L.
    Odland, Dwight
    Pei, York
    Perrone, Ronald D.
    Pirson, Yves
    Schrier, Robert W.
    Torra, Roser
    Torres, Vicente E.
    Watnick, Terry
    Wheeler, David C.
    [J]. KIDNEY INTERNATIONAL, 2015, 88 (01) : 17 - 27
  • [7] Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
    Chapman, Arlene B.
    Bost, James E.
    Torres, Vicente E.
    Guay-Woodford, Lisa
    Bae, Kyongtae Ty
    Landsittel, Douglas
    Li, Jie
    King, Bernard F.
    Martin, Diego
    Wetzel, Louis H.
    Lockhart, Mark E.
    Harris, Peter C.
    Moxey-Mims, Marva
    Flessner, Mike
    Bennett, William M.
    Grantham, Jared J.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 479 - 486
  • [8] Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
    Chebib, Fouad T.
    Torres, Vicente E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (11): : 1765 - 1776
  • [9] Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease
    Chebib, Fouad T.
    Jung, Yeonsoon
    Heyer, Christina M.
    Irazabal, Maria V.
    Hogan, Marie C.
    Harris, Peter C.
    Torres, Vicente E.
    El-Zoghby, Ziad M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (06) : 952 - 960
  • [10] Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016
    Chebib, Fouad T.
    Torres, Vicente E.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : 792 - 810
12345678